Meyka AI API is live for developers.Start building.
Advertisement
Orexo AB (publ)

Orexo AB (publ) (ORXOF) Stock Overview

Explore Orexo AB (publ)’s financial performance, market position, analyst ratings, and future outlook.

ORXOFPNK
HealthcareDrug Manufacturers - Specialty & Generic
$2.10
$0.00(0.00%)
U.S. Market opens in 51h 45m
Advertisement

Orexo AB (publ) (ORXOF)

Meyka AI Score

Z

Key Financials

Market Cap73.8M
P/E Ratio-2.82
EPS (TTM)$-1.29
ROE-2.28%
Fundamental Analysis

AI Price Forecasts

1 Month$1.35
3 Months$3.28
1 Year Target$4.76

ORXOF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Orexo AB (publ) (ORXOF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 7.01, suggesting the stock is in an oversold condition. Our forecasting models predict significant price movements, with a 12-month target of $4.76.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -2.82 and a market capitalization of 73.8M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
-34.98%
6-Month Change
-31.15%
Year-to-Date (YTD) Change
-34.98%
1-Year Change
10.53%
3-Year Change
101.92%
5-Year Change
-65.57%
All-Time (Max) Change
-74.39%

Contact Information

46 1 87 80 88 00
P.O. Box 303, Uppsala, NaN, 751 05

Company Facts

110 Employees
IPO DateApr 11, 2013
CountrySE
Actively Trading

Frequently Asked Questions